WO1999048358A1 - Procedes de creation, de stockage et de mesure du degre d'hibernation, de poissons et coquillages pseudo-hibernant - Google Patents
Procedes de creation, de stockage et de mesure du degre d'hibernation, de poissons et coquillages pseudo-hibernant Download PDFInfo
- Publication number
- WO1999048358A1 WO1999048358A1 PCT/JP1999/001127 JP9901127W WO9948358A1 WO 1999048358 A1 WO1999048358 A1 WO 1999048358A1 JP 9901127 W JP9901127 W JP 9901127W WO 9948358 A1 WO9948358 A1 WO 9948358A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hibernation
- pseudo
- fish
- hibernating
- serum
- Prior art date
Links
- 230000006266 hibernation Effects 0.000 title claims abstract description 153
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 126
- 238000000034 method Methods 0.000 title claims abstract description 75
- 235000015170 shellfish Nutrition 0.000 title claims abstract description 73
- 210000002966 serum Anatomy 0.000 claims abstract description 75
- 239000000126 substance Substances 0.000 claims abstract description 74
- 241000124008 Mammalia Species 0.000 claims abstract description 29
- 239000003446 ligand Substances 0.000 claims abstract description 27
- 102000014187 peptide receptors Human genes 0.000 claims abstract description 24
- 108010011903 peptide receptors Proteins 0.000 claims abstract description 24
- 241001465754 Metazoa Species 0.000 claims description 56
- 235000014102 seafood Nutrition 0.000 claims description 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
- YFGBQHOOROIVKG-FKBYEOEOSA-N Met-enkephalin Chemical group C([C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 YFGBQHOOROIVKG-FKBYEOEOSA-N 0.000 claims description 23
- 108010042237 Methionine Enkephalin Proteins 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 12
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 11
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 238000002347 injection Methods 0.000 claims description 11
- 229940116269 uric acid Drugs 0.000 claims description 11
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 claims description 10
- 230000003204 osmotic effect Effects 0.000 claims description 10
- 230000035939 shock Effects 0.000 claims description 9
- 210000003200 peritoneal cavity Anatomy 0.000 claims description 6
- 102000003929 Transaminases Human genes 0.000 claims description 5
- 108090000340 Transaminases Proteins 0.000 claims description 5
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 claims description 3
- 229930195712 glutamate Natural products 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 abstract description 47
- 239000003399 opiate peptide Substances 0.000 abstract description 6
- 230000004083 survival effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 44
- ZHUJMSMQIPIPTF-IBURTVSXSA-N (2r)-2-[[(2s)-2-[[2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ZHUJMSMQIPIPTF-IBURTVSXSA-N 0.000 description 38
- 108010004028 Leucine-2-Alanine Enkephalin Proteins 0.000 description 37
- 239000000411 inducer Substances 0.000 description 31
- 230000007423 decrease Effects 0.000 description 26
- 230000006698 induction Effects 0.000 description 23
- 230000000241 respiratory effect Effects 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 230000036387 respiratory rate Effects 0.000 description 19
- 241000277275 Oncorhynchus mykiss Species 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 16
- 239000001301 oxygen Substances 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 230000037396 body weight Effects 0.000 description 15
- 230000036284 oxygen consumption Effects 0.000 description 14
- 230000035882 stress Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 102000009027 Albumins Human genes 0.000 description 10
- 108010088751 Albumins Proteins 0.000 description 10
- 241000277331 Salmonidae Species 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 210000002816 gill Anatomy 0.000 description 9
- 241000252229 Carassius auratus Species 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 8
- 239000002504 physiological saline solution Substances 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000238557 Decapoda Species 0.000 description 7
- 241000555745 Sciuridae Species 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000007958 sleep Effects 0.000 description 7
- 241000283925 Spermophilus Species 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 238000007912 intraperitoneal administration Methods 0.000 description 6
- 230000003907 kidney function Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241001417899 Oncorhynchus clarkii Species 0.000 description 5
- 230000037007 arousal Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 5
- 229960004127 naloxone Drugs 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 108010065372 Dynorphins Proteins 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 3
- 102400000242 Dynorphin A(1-17) Human genes 0.000 description 3
- 108010092674 Enkephalins Proteins 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 3
- 102000003729 Neprilysin Human genes 0.000 description 3
- 108090000028 Neprilysin Proteins 0.000 description 3
- 108010093625 Opioid Peptides Proteins 0.000 description 3
- 102000001490 Opioid Peptides Human genes 0.000 description 3
- 241001282110 Pagrus major Species 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 241001441722 Takifugu rubripes Species 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 238000009360 aquaculture Methods 0.000 description 3
- 244000144974 aquaculture Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 230000005059 dormancy Effects 0.000 description 3
- JMNJYGMAUMANNW-FIXZTSJVSA-N dynorphin a Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 JMNJYGMAUMANNW-FIXZTSJVSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 0 CCN(C*)C(*)[C@](*)O Chemical compound CCN(C*)C(*)[C@](*)O 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 2
- 108070000021 Opioid peptides receptors Proteins 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000003486 adipose tissue brown Anatomy 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- -1 become a problem Inorganic materials 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 241001044684 Amadina fasciata Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000947653 Fontinalis Species 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 108010022337 Leucine Enkephalin Proteins 0.000 description 1
- LSQXZIUREIDSHZ-ZJZGAYNASA-N Morphiceptin Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(N)=O)C1=CC=C(O)C=C1 LSQXZIUREIDSHZ-ZJZGAYNASA-N 0.000 description 1
- 241001327647 Oncorhynchus mykiss gairdneri Species 0.000 description 1
- 102100024622 Proenkephalin-B Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101150064053 Rffl gene Proteins 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 1
- 108010081351 morphiceptin Proteins 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008452 non REM sleep Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/50—Culture of aquatic animals of shellfish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K63/00—Receptacles for live fish, e.g. aquaria; Terraria
- A01K63/02—Receptacles specially adapted for transporting live fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Definitions
- the present invention relates to a method for producing a pseudo-hibernating fish and shellfish using a substance that induces hibernation and a method for awakening the same.
- the present invention relates to a method for producing pseudo-hibernating seafood by administering serum from a pseudo-hibernating animal to seafood, and a method for awakening the same.
- the transportation of live fish and shellfish, particularly cultured fish and shellfish, is carried out from hatchery to farm or from farm to farm.
- An object of the present invention is to establish a method of inducing, maintaining, or awakening from a physiologically close to hibernating state (hereinafter, referred to as pseudo-hibernation) for seafood that does not naturally hibernate, and thus surviving Establish safe and efficient methods for storing and transporting live fish> _.
- pseudo-hibernation a physiologically close to hibernating state
- a physiological change is caused by a decrease in environmental temperature or a change in photoperiod as a signal, and a decrease in body temperature in response to a decrease in external temperature results in a hibernation. It is thought that it will be done.
- Hibernation is associated with hypothermia, extreme loss of appetite, and consequent cessation of digestive activity and elimination, a decrease in heart rate and blood pressure due to reduced cardiac function, and a complete cessation of urine output due to reduced renal function. Etc. are characteristic.
- Hibernation is, to be precise, a complex state in which unit cycles of 1) isothermal period, 2) induction period, 3) deep hibernation period, and 4) arousal period are repeated, and mammals regularly spontaneously during hibernation. Arousal is taking place.
- Hibernation Inducing Trigger a substance present in the serum of mammals in deep hibernation or the albumin fraction in the serum, in “Transportation method of live fish by induction of similar hibernation” (Japanese Patent Application No. 9-193387).
- HIT Hibernation Inducing Trigger
- pseudo-hibernation the fish and shellfish become physiologically close to hibernation
- HIT was collected from mammals in deep hibernation and prepared as HIT, the preparation was complicated, and the amount of preparation was limited.
- the present invention provides a method for inducing a pseudo-hibernation of an animal to which a hibernation-inducing substance is administered, the serum of the animal in which the pseudo-hibernation is induced is used, and the other serum is secondarily induced in the pseudo-hibernation using the serum.
- the purpose is to provide. Disclosure of the invention
- hibernation or a state similar to hibernation is induced by hibernation or a hibernation-inducing substance synergistic obioid peptide not only in fish and shellfish, but also in vertebrate animals including vertebrate and vertebrate animals. And even animals that induced hibernation artificially Over time, we found that hibernation or a substance that induces hibernation appeared in the serum, which caused secondary hibernation.
- the present inventor has applied this finding to fish and shellfish, and originally used a hibernation-inducing substance and a hibernation-awakening substance, in particular, a serum of a hibernating mammal, an obioid peptide or a ligand of an obioid peptide receptor, to thereby obtain a natural product. While hibernating, it succeeded in inducing pseudo-hibernation for seafood. Furthermore, the present inventors succeeded in maintaining the hibernation state and awakening from the hibernation state, and subsequently established a method for measuring the pseudo-hibernation state of fish and shellfish, thereby completing the present invention.
- the present invention includes the embodiments described in the following items.
- a method for producing pseudo-hibernating seafood which comprises administering one or more substances selected from the serum of a hibernating animal, a delta-obioid peptide, and a ligand of a delta-obioid peptide receptor to live fish and shellfish. .
- the pseudo-hibernating seafood described in any of paragraphs (1) to (5) is a method in which administration to live fish and shellfish is performed by introduction from gills or lateral lines using osmotic shock. Production method.
- a method for preserving live fish and shellfish which comprises administering an awakening substance after a certain period of time to the fish and shellfish pseudo-hibernated by the production method described in (1).
- the substance that wakes up is one or more substances selected from kappa-bioide peptides, myoebioide peptides, ligands for force-tuvoide peptide receptors, and ligands for mu-bioioid peptide receptors. 8.
- GAT glutamic acid-oxacetate transaminase
- GPT glutamate-pyruvate transaminase
- BUN serum urea nitrogen
- a method for inducing pseudo-hibernation of fish and shellfish comprising administering to the animal a substance that induces spontaneous hibernation or a substance that induces pseudo-hibernation, and collecting serum of the animal during pseudo-hibernation, By administering this serum to fish and shellfish, pseudo-hibernation of the fish and shellfish is induced to produce pseudo-hibernating fish and shellfish.
- the mechanism of hibernation is still largely unknown, and it is certain that the serum of hibernating animals contains a substance that induces hibernation, but the substance is not clear.
- FIG. 1 shows the relationship between the respiratory rate and the elapsed time after administration of a hibernation inducer in goldfish.
- Fig. 2 shows the respiratory volume after administration of a hibernation inducer to Brook Trout by intraperitoneal injection.
- FIG. 3 is a diagram showing the relationship between respiratory volume and elapsed time after administration of a hibernation-inducing substance to block trauma by intracerebrospinal fluid injection
- FIG. Fig. 5 is a graph showing the relationship between the respiratory volume and the elapsed time after administration of a hibernation inducer to a juvenile squid population, Fig. 5 is a graph showing physiological changes caused by pseudo-hibernation induction of the Japanese turtle, Fig. 6 Fig.
- FIG. 9 (a) is a diagram showing the relationship between the elapsed time after administration
- FIG. 9 (a) is a diagram showing the relationship between the movement of the tail fin of the cut throat trawl and the elapsed time after administration of the hibernation inducer.
- FIG. 15 (a) and Fig. 15 (b) are diagram showing the relationship between the number of gill respirations of cut throat trout and the elapsed time after administration of the hibernation inducer.
- FIG. 11 is a graph showing the relationship between the ratio of the ⁇ average diameter of the hibernation inducer '' and the elapsed time after administration of the hibernation inducer.
- FIG. 12 is a diagram showing the relationship between the oxygen respiratory volume of a aviation and the elapsed time after administration of the hibernation inducer, and FIG. Fig. 14 (a) and Fig. 14 (b) show the relationship between the elapsed time and the elapsed time.
- FIG. 16 is a diagram showing the respiration volume of Troughfish. is there.
- the symbols in FIG. 16 indicate the respiratory volume of troughs administered with physiological saline, and the respiratory volume of troughs administered with rainbow trout serum induced by pseudo-hibernation by DADLE administration.
- the present inventors have found that fish, which is a thermophilic vertebrate, are not known to hibernate, but when a hibernation inducer is administered, respiratory volume decreases, hepatic renal function decreases, and it is observed that Similarly, it was confirmed that it was physiologically controlled to be in a state close to hibernation (hereinafter referred to as pseudo-hibernation).
- the present invention provides a method for administering pseudo-hibernation to another animal by administering the serum of an animal to which pseudo-hibernation has been induced by administering a hibernation-inducing substance to another animal. It manufactures pseudo-hibernating seafood.
- pseudo-hibernation of another animal can be induced from the serum of the animal in which pseudo-hibernation has been induced, HIT and deltaopio collected from the serum of the hibernating mammal can be obtained. Since there is no need to use a hibernation-inducing substance such as an id peptide for each individual, pseudo-hibernation induction can be performed at low cost.
- a pseudo-hibernation induction method of the present invention a pseudo-hibernation is induced by administering a hibernation-inducing substance to an animal, and the pseudo-hibernation of another animal is gradually induced from the serum of the pseudo-hibernation-induced animal. This makes it possible to efficiently store and transport animals (eg, fish and shellfish) at low cost.
- animals eg, fish and shellfish
- Hibernation generally means that animals spend most of their life in winter with little or no activity. Hibernation animals sense seasonal changes and take sufficient nutrients before winter to store fat in brown adipose tissue. A decrease in the temperature of the environment or a change in photoperiod is a signal that causes physiological changes and induces hibernation, but results in a decrease in body temperature in response to a decrease in the external temperature. During hibernation, extreme loss of appetite and consequent cessation of digestive activity and elimination, a decrease in heart rate and blood pressure due to decreased cardiac function, and a complete cessation of urinary excretion due to reduced renal function Etc. occur.
- hibernation is considered to be a complex state in which unit cycles of 1) isothermal period, 2) induction period, 3) deep hibernation period, and 4) arousal period are repeated.
- the isothermal period is when the body temperature recovers, but the animal does not wake up during hibernation, but resembles a sleep state, consisting of REM (REM) and non-REM (NREM) sleep. It is.
- the induction period consists of so-called wakefulness (WAK) and REM (REM) sleep, and is a period in which rapid declines in body temperature and physiological activity are observed.
- Deep hibernation refers to the period when the body temperature of a hibernating animal falls and reaches a temperature close to the ambient temperature, and non-REM (NREM) sleep is dominant.
- the awakening period is the period when energy is obtained by metabolizing fat and the cycle is returned to the constant temperature period.
- REM sleep (REM) and non-REM sleep (NREM) are periodically repeated, and the body, including the brain, is breathed. In hibernation, this activity is interrupted. It is believed that the debt of the interruption has been resolved by awakening (B. L. Krilowicz et al., (1988) Am. J. Physiol. 256, R1008-R1019).
- the same mammal Due to differences in the ratio of body surface area to body weight, the same mammal has a large mammal like a bear (smaller ratio) and a small mammal like a squirrel hedgehog. Have different hibernation mechanisms. For example, in large mammals such as bears, body temperature drops at most to 3 ° C (winter storm), and even during winter storms, there is complete arousal and closer to sleep. Also in bears, the metabolism of brown adipose tissue associated with awakening in bears is common to small mammals (RA Nelson et al., (1984) Science 226, 841-842, WL Davie et al. , (1990) Riochimica et Bioptiysica Acta. 1051, 276-278).
- Hibernation Inducing Trigger HIT
- the opioid peptide is not contained in HIT (Oeltgen, PR et al., (1988) Life Sciences 43, 1565-1574). Or a role for the Obioid peptide receptor is predicted (Margules, DL el al., (1979) Rain Res, Bull. 4, 721-724. Knowledge on rats: Swan, H. et. al., (1977) Science 195, 84-85, Findings about monkeys: Myers, RD, et al., (1981) Brain Res, Bull, 7, 691-695).
- Mu (), delta ( ⁇ 5), kappa (K) monoreceptors and the like are known as the obioid peptide receptors.
- Methionin enkephalin a kind of delta-obioid peptide, is found in the brains of deep hibernating animals about 10 times higher than in the awake state, and the serum of animals in deeper hibernating states Hibernation induced in summer The state was interrupted by the naloxone, an antagonist of the opioid peptide receptor, and the induction of hibernation by HIT was also inhibited.
- delta-obioid peptide and delta-obioid peptide receptor ligands are effective in inducing hibernation in mammals.
- mu- and bioactive peptide receptors are thought to be involved in arousal (Oeltgen, PR et al., (1988), Ueltgen, PR et al., (1988)). ).
- the hibernation-inducing substance and the hibernation-awakening substance used in the present invention are not particularly limited as long as they are substances that induce and wake up a pseudo-hibernation state in fish and shellfish, but more preferably HIT, Delta opioid peptide or delta opioid peptide receptor ligands can be used.
- a substance that wakes up hibernation muobioid peptide, kappabiooid peptide, a ligand of muobioid peptide receptor, or a ligand of a potato biooid peptide receptor can be used.
- the administration of the substance for inducing hibernation induces pseudo-hibernation of live fish and shellfish, but can be naturally recovered and awakened after an appropriate time.
- the time until awakening depends on the type and size of the target fish and shellfish, and the type of substance to be administered.
- administration of a substance that wakes up from hibernation can arbitrarily wake up fish and shellfish from pseudo-hibernation.
- HI ⁇ used to induce pseudo-hibernation in fish and shellfish can be obtained, for example, as an albumin fraction of serum of a mammal in deep hibernation. More specifically, for example, it can be obtained by the following method. That is, an affinity using a chromatographic carrier (eg, Affi ge 1b 1 ue, manufactured by Bio-Rad, etc.) that selectively adsorbs the albumin fraction contained in the serum of a hibernating animal. Two-column chromatography is effective.
- the affinity chromatography method can be performed according to a method generally used for isolating and purifying a physiologically active substance, and the following method is exemplified.
- Blood collected from the hibernating animal is centrifuged at about 1,000 X g for 20 minutes at 4 ° C to obtain a supernatant (serum).
- This Of the serum is removed using an ultrafiltration device (eg, Bio-Rad) to remove substances with a molecular weight of 5,000 or less, and then freeze-dried.
- an ultrafiltration device eg, Bio-Rad
- the non-albumin fraction elutes with 0.02M phosphate buffer at pH 6.8, followed by complete elution with 0.02M phosphate buffer at pH 5.7.
- the albumin fraction bound to the carrier in the column is eluted with a 0.2 M phosphate buffer (pH 5.7) containing 1.4 M sodium chloride, and immediately subjected to ultrafiltration (molecular weight cut: 5,000 or less) to salt. Is removed.
- the albumin fraction obtained here can be stored until use by freeze-drying.
- HIT used in the present invention in addition to those used as the albumin fraction as described above, serum of a mammal during deep hibernation, which contains a large amount of HIT, is preferably used.
- the target mammals include squirrels such as ground squirrels, chipmunks and squirrels in winter hibernation, and those collected from bears.
- an extract of an organ or the like that produces HIT for example, ligens / liver
- HIT for example, ligens / liver
- Derby Obioid peptide can be used. Specific examples include methionine enkephalin, leucine enkephalin, / 3-endorphin and the like, and preferably, methionine enkephalin (Tyr-Gly-Gly-Phe-Met) is used. Further, as a ligand of the Derma obiooid peptide receptor used for inducing and maintaining pseudo-hibernation of fish and shellfish, DAD LE (Tyr-D-Ala-Gly-Phe-D-Leu) and the like can be mentioned.
- mu- and kappa-bioiod peptides which are a kind of obioid peptides, can be used.
- the miu and potato bioiodide peptide receptor ligands used to wake up pseudo-hibernation in seafood include dynorphin 8, morphiceptin and the like.
- a mammalian tissue that produces the substance, particularly one extracted as a composition from the brain, but preferably the composition is further used.
- Purified products are used, more preferably, synthesized products, which are commercially available. If they do not exist in nature, they can be synthesized by known techniques, and these are also commercially available.
- Methods of administering a hibernation-inducing substance or a hibernation-awakening substance to fish and shellfish include osmotic shock-induced introduction from the gill or lateral line, injection into the rffl tube, into the peritoneal cavity or into the cerebrospinal fluid.
- the osmotic shock is performed, for example, by the following method.
- the target fish and shellfish are transferred from the breeding aquarium to an aquarium containing 800 to 1,800 milliosmols, preferably 1,100 milliosmols of saline, and are added to the saline for 0.5 to 5 minutes, preferably 2 minutes. Soak.
- the concentration of the hibernation-inducing substance or hibernation-inducing substance used in the aquarium used here varies depending on the substance used.
- 2 to 50 n for potato bioioid peptide / mL preferably 15 gZmL, 2 ⁇ 50 gZmL for muobioid peptide, preferably 2 ⁇ 50 ng / mL for 1 S gZml ⁇ dynorphin A or morphiseptin, preferably at a concentration of 15 gZmL, respectively.
- the saline, hibernation-inducing substance solution, and hibernation-awakening substance solution used in this treatment can be used repeatedly for fry up to a cumulative total weight of fry of 50-100 g without replacement. Dosage via osmotic shock or gill or shunt introduction is suitable for small or juvenile fish and is effective for transport from hatchery to aquaculture.
- tail fins when administering using a syringe (needle gauge is appropriately selected according to the type, length or weight of the target fish), for example, in the case of intravascular administration, tail fins
- the inducer should be prepared concentrated using a buffer solution that does not affect fish and shellfish, such as physiological saline, and if administered intravascularly or in the cerebrospinal fluid, the inducer should be expressed as the volume per g of body weight. It is preferable that the amount does not exceed 2.5 / L, and in the case of intraperitoneal administration, the amount does not exceed 1 per gram of body weight.
- the dosage may be, for example, 0.5 to 2 / L, preferably 1 ⁇ L for serum of a mammal in deep hibernation, preferably 1 ⁇ L, for HIT, per 1 g of body weight.
- methionine enkephalin which is a delta oboioid peptide, or a ligand for its receptor (for example, DADLE), kappa obioide peptide or 0.2-10 g, preferably 0.8 g, for the ligand of the receptor (eg, dynorphin A), 0.2-10 g, preferably 0.8 g for the muobioid peptide or the ligand of the receptor (eg, morphoiseptin) Or a dose of 0.8 ag.
- the dose may be, for example, 2 to 10 / L, preferably 5 L for sera of mammals in deep hibernation, and 5 to 45 g for HIT per gram of body weight. 15 g, preferably 2 to 10 / g, preferably 5 g for methionine enkephalin or its receptor ligand (eg, DADLE), which is a delta-obide peptide, and its receptor or its receptor. 2 to 10 8, preferably 5 g, for the ligand of the body (for example, dynorphin A), 2 to 10 ag for the ligand of the mu-opioid peptide or its receptor (for example, mo-fuseptin), preferably 5 g. It is used in each dose.
- the method of administration by injection is suitable for adult, medium and large fish, and is effective for transport from fishing grounds or farms to markets.
- a pseudo-hibernation state is induced and maintained for the fish and shellfish, or By utilizing the method of awakening from that state, it becomes possible to store and transport live fish efficiently.
- the hibernation-inducing substance and the hibernation-awake substance are derived from biological components or have properties very close to biological components, so that they are excellent in safety.
- a method of storing and transporting live fish for example, specifically, administering a hibernation inducer according to the method of inducing pseudo-hibernation in fish and shellfish, storing the product in a pseudo-hibernation state, and in a pseudo-hibernation state Awakening the fry transported according to the method of transporting the preserved live fish to the market, transporting the fry preserved in a pseudo-hibernation state to the aquaculture farm, and after transport, awakening from the pseudo-hibernation state, A method of continuing aquaculture and the like can be mentioned.
- Conventional containers such as aquariums used for storage and transportation can be used, but as described above, seafood in a quasi-hibernating state has a low physiological activity, and therefore has a low oxygen consumption and waste products. Since it can be kept low, the decrease in pH and the accumulation of harmful ammonia due to the increase in carbon dioxide gas are also small, and the change in water quality can be extremely suppressed. Therefore, more fish and shellfish can be stored at once, and ventilation and water exchange are not required.
- the present invention further provides a measurement method for more accurately and quantitatively grasping the pseudo-hibernation state of fish and shellfish.
- a measurement method for more accurately and quantitatively grasping the pseudo-hibernation state of fish and shellfish In order to measure the induction of pseudo-hibernation of fish and shellfish in the present invention, it is necessary to determine the amount of glutamate monooxacetate transaminase (GOT), glutamate monopyruvate transaminase (GPT), serum urea nitrogen (BUN) or serum uric acid (UA).
- GAT glutamate monooxacetate transaminase
- GPT glutamate monopyruvate transaminase
- BUN serum urea nitrogen
- U serum uric acid
- a method usually used in a human serum test can be used. These are also commercially available and available as kits. The measurement can be easily performed by using the kit.
- the method of collecting the serum of the fish and shellfish used as the sample is preferably a method that can collect the amount required for each test, but if only a small amount can be collected, increase the number of target seafood and increase the serum. It can be measured by mixing.
- a small (approximately 5.6 cm long, approximately 0.5 g body weight) goldfish (Carassius auratus) suitable for this method was used in a mixed sex.
- DADLE manufactured by Sigma
- the effect of inducing hibernation was apparent in respiration, so the effect of inducing hibernation was measured by measuring the respiratory rate.
- the substance was introduced by injection into the peritoneal cavity or cerebrospinal fluid.
- Brook Traut Salvelius fontinalis
- Example 1 Serum collected from ground squirrels (ground squirrel-Citellus tridcceralineatus captured in the suburbs of Laramie, Wyoming, USA) at 5 weeks of hibernation, methionine enkephalin (manufactured by Sigma) and DAD LE was used.
- Bunolek trout 2-3 years old, weighing 10-12 g, and 3 cm in length were collected from a mountain stream and used by mixing male and female.
- the specific method is as follows.
- Each of the various hibernating inducers was administered to the belly about 2 cm above the anus of Brooktraut using a 24 G needle using a syringe.
- the dose of each hibernation inducer is 5.0 / L for hibernating ground squirrel serum, 5 g for methionine enkephalin, and 5 ⁇ g for DAD LE per lg of body weight of the target seafood. did.
- Physiological saline was used as a control instead of each hibernation inducer.
- the value converted per 1 g body weight was defined as the oxygen consumption at that time (ppmZminZg).
- the dissolved oxygen amount was measured by inserting a probe of a dissolved oxygen meter (DO meter) into water. In order to minimize the stress on the fish, open containers such as beakers were used. The results are shown in FIG.
- Intraperitoneal administration had only a partial effect with ground squirrel serum and methionine enkephalin, whereas DAD LE significantly reduced respiratory Down to. Wild Brook Trout collected from a mountain stream was sensitive to external stimuli, but was insensitive to external stimuli as it could be lifted by hand while respiratory rate was low. The effect appeared quickly and lasted for about 2 hours. These observations suggest that the stability of the hibernation-inducing substance reflects the degree of induction. Immediately, the serum of local squirrel and methionine enkephalin were considered to be degraded while passing through the lungs in the bloodstream, making it difficult to reach specific parts of the brain. On the other hand, DADLE, which is substituted with two D-type amino acids, functions as a ligand for the obioid peptide receptor, but is unlikely to be a major degrading enzyme substrate.
- hibernation-inducing substances were introduced into fish and shellfish by injection into the cerebrospinal fluid.
- the target fish and shellfish, and the substance to induce hibernation to be administered were the same as those used for intraperitoneal administration described above.
- the cerebrospinal fluid was administered using a 26G x 1/2 "needle using a syringe. The soft part immediately behind the fish skull was gently injected into the cerebrospinal fluid so as not to damage the cerebral spinal cord.
- Example 2 Except for processing the whole basket containing the fry group, the same treatment as in Example 1 was performed with DADLE treatment and control treatment. After the treatment, the whole basket was placed in a closed container, and a small amount bottle (lOOraL) was placed through the water sampling port. The water sampled in) was used as a 0-minute sample, and after 15 minutes, water was sampled again and used as a 15-minute sample. A set of a 0-minute sample and a 15-minute sample was prepared before processing, and at 20, 40, 60, and 80 minutes after processing, and the dissolved oxygen content was determined by the Winkler method described above for 15 minutes. The difference between the dissolved oxygen amount of the sample and the 0-minute sample was defined as the oxygen consumption at that time. The results are shown in FIG. As is clear from Fig. 4,
- GAT glutamate-oxaloacetate transaminase
- GPT glutamate-pyruvate transaminase
- AY amylase
- Serum urea nitrogen (BUN), creatinine (CRE) and The activity or amount of serum uric acid (UA), blood glucose (GLU), and inorganic phosphate (IP) were measured. The measurement was carried out using Ultra Liquid, Daikara Liquid, Pericolor Liquid (all manufactured by Toyobo Co., Ltd.) according to the attached instruction manual.
- the serum used as the sample was prepared as follows.
- the DADLE treatment and the control treatment were performed in accordance with the intraperitoneal administration of Example 2 except that the target fish and shellfish were cut throat trout (average body length 12 cm, average body weight 3.9 g). Subsequently, the cutthroat trout that induced pseudo-hibernation by DADLE was removed from the aquarium immediately after induction, and at 20, 40, and 60 minutes after induction, and the laparotomy was performed quickly.
- the artery between the heart and gill was cut with scissors, and the blood was collected with a 1 mL syringe, collected in a microcentrifuge tube, and centrifuged (6,000 xg, 3 minutes) to obtain serum as a supernatant.
- Pseudo-hibernation was administered to freshwater fish by hibernating squirrel serum, and respiratory volume during pseudo-hibernation was measured.
- Fig. 7 shows the measurement results.
- Fig. 8 shows the measurement results.
- the animal's hibernation status was assessed by its behavior rather than by physiological methods.
- Behavior reflects not only physiological changes but also global changes in animals.
- Fig. 9 (a) and Fig. 9 (b) both measure the movement of the tail fin and the movement of the gills using a cut throat trout.
- the movement of the tail fin is due to muscular activity, and various physiological changes intervene as factors.
- One trout in diameter The water was placed in a 90 cm tub, and dechlorinated water was poured to prevent water from staying inside the tub. As a result, the trout is washed away unless the tail fin is moved, and the trout is forced to move constantly. Under these conditions, the behavior was evaluated by counting the number of exercises of the tail fins of the control fish fed with saline and the sample fish fed with methionine enkephalin.
- the control that gave saline to the movement of the tail fin was the one that gave methionine enkephalin, a force that made a remarkable movement from the stress of injection after 10 minutes, and this stress was avoided. Exactly the same behavior pattern is reflected in breathing. Here, evaluation was made by observing the movement of gills, not respiratory volume.
- the shrimp treated with DADLE clearly had a lower respiratory rate than the control shrimp, and the effect lasted from 30 minutes to 2 hours after administration.
- shrimp given DAD LE and naloxone at the same time did not show such effects and showed the same changes as the control shrimp. Therefore, it was confirmed that methionine 'enkephalin acts specifically on crustaceans and induces hibernation.
- the fluctuation of respiratory rate in shrimp tends to gradually increase with time in this experiment, but this may be considered as stress when measuring the respiratory rate.
- control penis which received saline, showed a tendency for the respiratory rate to rise temporarily 30 minutes after administration and then to gradually decrease.
- DAD LE was administered to rainbow trout to induce pseudo-hibernation, and serum prepared from the rainbow trout was again administered to a power throat trout to examine whether secondary pseudo-hibernation was induced.
- the evaluation was performed by testing serum.
- the activity or amount of GOT, GPT, UA, and BUN in the serum of a pittle-mouth trout 30 minutes after administration was measured in the same manner as in Example 4, and the results were shown in FIG. 14 (a) and FIG. (b) It is shown in the figure.
- pitted throat trout treated with secondary serum showed the same effect as DADLE treatment compared to control (treated with saline), and rainbow trout in which pseudo-hibernation was induced once. It was found that the serum contained a substance that induces hibernation.
- methionine enkephalinka which is a kind of an obioid peptide recognized as a brain hormone, induces hibernation in seafood.
- Methionin enkephalin is captured in hibernating mammals as a key substance that induces hibernation in winter, and can induce hibernation in mammals even in summer.
- this substance can be used to induce a state similar to hibernation in fish and shellfish, that is, a pseudo-hibernation state, and the effect can be used to transport or preserve fish and shellfish.
- administration of hibernating squirrel serum, methionine enkephalin, and the like to the body of the fish caused a temporary decrease in the respiratory rate of the fish.
- administration by intraperitoneal injection is most effective for goldfish, carp, trout, etc., in which case the serum components of the fish are specifically changed, and the liver and kidney functions may be significantly changed. Sharing Was.
- a substance that induces pseudo-hibernation is administered to rainbow trout to induce a state of pseudo-hibernation (primary pseudo-hibernation), serum is removed from the rainbow trout to which the pseudo-hibernation-inducing substance is administered, and administered to another animal (Trafugu).
- a method for producing a pseudo-hibernating tortoise was introduced by introducing the aforementioned torchfish into a pseudo-hibernation state (secondary pseudo-hibernation).
- DADLE manufactured by Osaka Peptide Co., Ltd.
- Osaka Peptide Co., Ltd. which is a ligand of the Deruba Obioid peptide receptor
- a rainbow trout (scientific name: Salmo gair dneri), a body weight of about 250 g, and a body length of 25 cm to 35 cm was used as a test object to induce primary pseudo-hibernation.
- the hibernation inducer was administered intraperitoneally to DADLE with a syringe using a 24 G needle in the abdomen 5 cm above the rainbow trout anus.
- the dose of DADLE was 5 g per gram of body weight of each target fish.
- DADLE was administered to 10 rainbow trout, including males and females.
- the rainbow trout was raised in a breeding aquarium through which groundwater flows freely to avoid physiological errors and to give no food for 24 hours before the test and to avoid physiological stress.
- the rainbow trout was taken out of the breeding aquarium, DADLE was injected intraperitoneally with a syringe, and then released into another aquarium. Thereafter, serum of rainbow trout in a pseudo-hibernation state 20 minutes after administration of the hibernation inducer was collected.
- the tiger puffer (scientific name: Fugu rubripes) used in this example was 10 months old, weighed about 120 g, and was 15 cm to 2 Ocm in length.
- the rainbow trout serum was administered to the abdomen 5 cm above the anus of 10 male pufferfish, including males and females, using a syringe with a 24 G needle at 0.2 L / g body weight of the target fish.
- physiological saline was administered in the same manner to 10 tiger puffer fish.
- the closed container containing the trough was covered with a lid, ventilated into the atmosphere, and placed in a large water tank through which seawater flows. Seawater in the sealed container in this state was collected as the first sample. In addition, seawater 20 minutes after the container was sealed was sampled as the second sample.
- the oxygen dissolved amount (DO) of each of the first sample and the second sample was measured, and the difference was converted into lg of fish body weight and per volume of closed container (5.7 L), and the absolute oxygen consumption of fish was calculated for 1 hour. Respiratory volume per unit (mgOzZgrZhr).
- the results are shown in FIG.
- the T bar on the graph indicates the standard error.
- 2 in the figure is the rainbow trout serum induced by pseudo-hibernation by DADLE in this example.
- the mean respiratory volume of the fish (n 10) that was administered and secondary induced pseudo-hibernation was shown.
- pseudo-hibernation is induced by a hibernation-inducing substance
- the serum of the animal is collected, and administered to another animal, whereby the other animal can be secondarily induced by pseudo-hibernation.
- animals can be induced into pseudo-hibernation, and the cost of pseudo-hibernation induction can be reduced.
- pseudo-hibernation can be induced by administration of serum to allogeneic individuals, which is excellent in terms of safety.
- a method for producing pseudo-hibernating fish and shellfish can be achieved efficiently and economically by a method for inducing pseudo-hibernation of fish and shellfish secondary.
- pseudo-hibernation can be induced by using serum containing substances that animals naturally produce for their survival, and therefore they are also excellent in terms of safety.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention porte sur une méthode de création de poissons et coquillages pseudo-hibernants consistant à administrer à des poissons et coquillages une ou plusieurs substances sélectionnées dans le sérum d'un mammifère hibernant en cours d'hibernation, ainsi que des delta-opioïdes et des ligands du récepteur du delta-opioïde. Cette méthode met les poissons et coquillages n'hibernant pas naturellement dans un état proche de l'hibernation, dit pseudo-hibernation, où ils sont maintenus jusqu'à leur réveil. Elle permet donc de stocker et transporter avec sûreté des poissons frais avec un taux élevé de survie et une grande efficacité.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32758/99A AU3275899A (en) | 1998-03-20 | 1999-03-08 | Method for constructing pseudo-hibernant fishes and shellfishes, method for storing fresh fishes and shellfishes and method for measuring degree of hibernation of pseudo-hibernant fisches and shellfishes |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10/72462 | 1998-03-20 | ||
JP7246298 | 1998-03-20 | ||
JP14610298A JPH11318273A (ja) | 1998-03-20 | 1998-05-27 | 動物の疑似冬眠誘導方法 |
JP10/146102 | 1998-05-27 | ||
JP28704798A JP2000106787A (ja) | 1998-10-08 | 1998-10-08 | 魚介類の製造方法 |
JP10/287047 | 1998-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999048358A1 true WO1999048358A1 (fr) | 1999-09-30 |
Family
ID=27300964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1999/001127 WO1999048358A1 (fr) | 1998-03-20 | 1999-03-08 | Procedes de creation, de stockage et de mesure du degre d'hibernation, de poissons et coquillages pseudo-hibernant |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3275899A (fr) |
WO (1) | WO1999048358A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3289864A4 (fr) * | 2015-04-30 | 2019-02-13 | University Industry Foundation, Yonsei University Wonju Campus | Composition pour induire un hypométabolisme, procédé pour induire un hypométabolisme, et procédé de transport de poisson utilisant ses techniques |
CN109430158A (zh) * | 2018-11-05 | 2019-03-08 | 贵港市庄满园农业服务有限公司 | 一种便于清洗及保护乌龟的乌龟饲养盒 |
-
1999
- 1999-03-08 AU AU32758/99A patent/AU3275899A/en not_active Abandoned
- 1999-03-08 WO PCT/JP1999/001127 patent/WO1999048358A1/fr active Application Filing
Non-Patent Citations (5)
Title |
---|
AZIZ S, HASNAIN S N, ZAIN B K: "EFFECT OF CORTISONE ON ASPARTATE AND ALANINE AMINOTRANSFERASES IN ADESERT LIZARD", ZEITSCHRIFT FUER NATURFORSCHUNG. SECTION C: A JOURNAL OF BIOSCIENCES, WALTER DE GRUYTER GMBH, DE, 1 January 1978 (1978-01-01), DE, pages 70 - 72, XP002922241, ISSN: 0341-0382 * |
JEWETT D C, MOSBERG H I, WOODS J H: "DISCRIMINATIVE STIMULUS EFFECTS OF A CENTRALLY ADMINISTERED DELTA-OPLOID PEPTIDE (D-PEN2-D-PEN5-ENKEPHALIN) IN PIGEONS", PSYCHOPHARMACOLOGY., SPRINGER VERLAG, BERLIN., DE, vol. 127, 1 January 1996 (1996-01-01), DE, pages 225 - 230, XP002922244, ISSN: 0033-3158, DOI: 10.1007/s002130050080 * |
KADOKAMI Y: "A MIMIC HIBERNATION FOR TRANSPORTATION AND PRESERVATION OF LIVE FISH: ITS POSSIBILITY AND FUTURE USE", SUISAN ZOSHOKU, SUISAN ZOSHOKU DANWA KAI, TOKYO,, JP, vol. 46, no. 03, 1 January 1998 (1998-01-01), JP, pages 469 - 470, XP002922240, ISSN: 0371-4217 * |
VYBIRAL S, JANSKY L: "HIBERNATION TRIGGERS AND CRYOGENS: DO THEY PLAY A ROLE IN HIBERNATION?", COMPERATIVE BIOCHEMISTRY AND PHYSIOLOGY., ELMSFORD, NY., US, vol. 118A, no. 04, 1 January 1997 (1997-01-01), US, pages 1125 - 1133, XP002922243, DOI: 10.1016/S0300-9629(97)00239-9 * |
ZHIDENKO A A, GRUBINKO V V, YAVONEIIKO A F: "PECULIARITIES OF INTERCONVERSION OF ALPHA-KETOGLUTORATE-GLUTAMATE IN BRAIN MITOCHONDRIA OF EXOTHERMAL ANIMALS UNDER HIBERNATION", UKRAINSKYI BIOKHIMICHNYI ZHURNAL - UKRAINIAN BIOCHEMICAL JOURNAL, AKADEMIYA NAUK UKRAINY, KIEV,, UA, vol. 62, no. 06, 16 February 1990 (1990-02-16), UA, pages 79 - 83, XP002922242, ISSN: 0201-8470 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3289864A4 (fr) * | 2015-04-30 | 2019-02-13 | University Industry Foundation, Yonsei University Wonju Campus | Composition pour induire un hypométabolisme, procédé pour induire un hypométabolisme, et procédé de transport de poisson utilisant ses techniques |
CN109430158A (zh) * | 2018-11-05 | 2019-03-08 | 贵港市庄满园农业服务有限公司 | 一种便于清洗及保护乌龟的乌龟饲养盒 |
Also Published As
Publication number | Publication date |
---|---|
AU3275899A (en) | 1999-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stefansson et al. | Smoltification | |
Lester | The influence of Schistocephalus plerocercoids on the respiration of Gasterosteus and a possible resulting effect on the behavior of the fish | |
Kim et al. | Effects of salinity on endogenous rhythm of the Manila clam, Ruditapes philippinarum (Bivalvia: Veneridae) | |
Tagawa et al. | Changes in tissue and blood concentrations of thyroid hormones in developing chum salmon | |
Jeng et al. | Effects of dietary zinc levels on zinc concentrations in tissues of common carp | |
Overton et al. | Salinity tolerance of cultured Eurasian perch, Perca fluviatilis L.: effects on growth and on survival as a function of temperature | |
Leray et al. | Time course of osmotic adaptation and gill energetics of rainbow trout (Salmo gairdneri R.) following abrupt changes in external salinity | |
Hemmingsen | Respiratory and cardiovascular adaptations in hemoglobin-free fish: resolved and unresolved problems | |
Olivereau et al. | Long-term starvation in the European eel: general effects and responses of pituitary growth hormone-(GH) and somatolactin-(SL) secreting cells | |
Whiteley et al. | A comparison of the metabolic cost of protein synthesis in stenothermal and eurythermal isopod crustaceans | |
MacCormack et al. | Changes in ventilation, metabolism, and behaviour, but not bradycardia, contribute to hypoxia survival in two species of Amazonian armoured catfish | |
Wetherbee et al. | X‐radiographic observations of food passage through digestive tracts of lemon sharks | |
Stinner et al. | Blood pressure during routine activity, stress, and feeding in black racer snakes (Coluber constrictor) | |
Weisel | Comparative study of the digestive tract of a sucker, Catostomus catostomus, and a predaceous minnow, Ptychocheilus oregonense | |
FI81722B (fi) | Foerfarande foer tillvaratagande av produkter som aer faerdiga foer befruktning fraon sexuellt mogna fiskar. | |
WO1999048358A1 (fr) | Procedes de creation, de stockage et de mesure du degre d'hibernation, de poissons et coquillages pseudo-hibernant | |
Harrell | Stress mitigation by use of salt and anesthetic for wild striped bass captured for brood stock | |
Swan et al. | Metabolic torpor in Protopterus aethiopicus: an anti-metabolic agent from the brain | |
Pritchard et al. | Metabolism and oxygen transport in the innkeeper Urechis caupo | |
Min et al. | Stress responses of starry flounder, Platichthys stellatus (Pallas) following water temperature rise | |
JPH11220974A (ja) | 魚介類の疑似冬眠誘導方法及びそれを用いた活魚輸送方法 | |
Close | Effects of acute stress and tagging on the swimming performance and physiology of Pacific lampreys (Lampetra tridentata) | |
JPH10276612A (ja) | 冬眠誘導物質を用いた魚介類の疑似冬眠誘導による活魚輸送法 | |
JP2000106787A (ja) | 魚介類の製造方法 | |
Chen et al. | Responses of hemolymph osmolality and tissue water of Penaeus chinensis Osbeck juveniles subjected to sudden change in salinity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN ID IL IS KR MX NO NZ SG TR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
122 | Ep: pct application non-entry in european phase |